CDKN2B and hepatocellular carcinoma: Moreover, mutations in SMAD2 and SMAD4 genes have been observed in HCC which can result in cell cycle progression via disruption of cyclin inhibitors, such as p15INK4b and p21CIP1 [33,34,35,36].